Molecular Analysis of Microdissected Human Lenses

显微解剖人体晶状体的分子分析

基本信息

  • 批准号:
    8020927
  • 负责人:
  • 金额:
    $ 34.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-30 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The central premise of this proposal is that the lens has evolved several key protective and repair systems that maintain its transparent function and that an age-related decrease in the function of these systems contributes to age-related cataract. A hallmark of human lens aging and cataract formation is oxidation of protein methionines to protein methionine sulfoxide (PMSO). PMSO levels increase in the human lens with age and in human age-related cataract, 60% of total lens protein is found as PMSO. PMSO causes loss of protein function, protein aggregation and cell death. However, to date, the role of PMSO in lens aging and cataract formation has not been established. One key to unlocking the role of PMSO in lens aging and cataract formation is to identify those repair mechanisms that the lens has evolved to defend against PMSO damage and those proteins whose functions are lost upon methionine sulfoxide (MSO) formation. We have discovered that a novel PMSO repair enzyme called methionine sulfoxide reductase A (MsrA) is essential for lens defense against oxidative stress, viability, and defense against cataract formation. Since PMSO accumulates in the human lens with increasing age and since MsrA activity is essential for cataract resistance, it is likely that loss of MsrA repair of one or more lens proteins oxidized to PMSO upon aging and/or oxidative stress contributes to loss of protein function and cataract. A likely target for MsrA repair is ?-crystallin, which exists in the lens as an oligomer of two subunits (? A and ? B) each containing two conserved methionines. In addition to its role as a structural lens crystallin, ? -crystallin is essential for lens function through its ability to act as a molecular chaperone that protects lens proteins against age-related damage. This application will test the hypothesis that oxidation of ? -crystallin to methionine sulfoxide (? -crystallin-MSO) causes loss of chaperone function and that MsrA can repair and restore the chaperone function of ? -crystallin-MSO. Thus, loss of MsrA activity upon aging could result in increased levels of ? -crystallin-MSO, loss of lens chaperone function and ultimately cataract formation. The results of these studies will provide a novel mechanism for cataract development and an innovative model describing the interdependent functions of key lens protective and repair systems. The information gained from this work could have a major impact on the rational design of therapeutics based on increasing the activity of MsrA thereby preventing cataract formation. PUBLIC HEALTH RELEVANCE: The lens has evolved several key protective and repair systems that maintain its transparent function and an age-related decrease in the function of these systems contributes to age-related cataract the leading cause of visual impairment world-wide. The information gained from this work will have a major impact on the rational design of therapeutics that could prevent cataract formation.
DESCRIPTION (provided by applicant): The central premise of this proposal is that the lens has evolved several key protective and repair systems that maintain its transparent function and that an age-related decrease in the function of these systems contributes to age-related cataract. A hallmark of human lens aging and cataract formation is oxidation of protein methionines to protein methionine sulfoxide (PMSO). PMSO levels increase in the human lens with age and in human age-related cataract, 60% of total lens protein is found as PMSO. PMSO causes loss of protein function, protein aggregation and cell death. However, to date, the role of PMSO in lens aging and cataract formation has not been established. One key to unlocking the role of PMSO in lens aging and cataract formation is to identify those repair mechanisms that the lens has evolved to defend against PMSO damage and those proteins whose functions are lost upon methionine sulfoxide (MSO) formation. We have discovered that a novel PMSO repair enzyme called methionine sulfoxide reductase A (MsrA) is essential for lens defense against oxidative stress, viability, and defense against cataract formation. Since PMSO accumulates in the human lens with increasing age and since MsrA activity is essential for cataract resistance, it is likely that loss of MsrA repair of one or more lens proteins oxidized to PMSO upon aging and/or oxidative stress contributes to loss of protein function and cataract. A likely target for MsrA repair is ?-crystallin, which exists in the lens as an oligomer of two subunits (? A and ? B) each containing two conserved methionines. In addition to its role as a structural lens crystallin, ? -crystallin is essential for lens function through its ability to act as a molecular chaperone that protects lens proteins against age-related damage. This application will test the hypothesis that oxidation of ? -crystallin to methionine sulfoxide (? -crystallin-MSO) causes loss of chaperone function and that MsrA can repair and restore the chaperone function of ? -crystallin-MSO. Thus, loss of MsrA activity upon aging could result in increased levels of ? -crystallin-MSO, loss of lens chaperone function and ultimately cataract formation. The results of these studies will provide a novel mechanism for cataract development and an innovative model describing the interdependent functions of key lens protective and repair systems. The information gained from this work could have a major impact on the rational design of therapeutics based on increasing the activity of MsrA thereby preventing cataract formation. PUBLIC HEALTH RELEVANCE: The lens has evolved several key protective and repair systems that maintain its transparent function and an age-related decrease in the function of these systems contributes to age-related cataract the leading cause of visual impairment world-wide. The information gained from this work will have a major impact on the rational design of therapeutics that could prevent cataract formation.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marc Kantorow其他文献

Marc Kantorow的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marc Kantorow', 18)}}的其他基金

Hypoxia Regulation of the Lens
晶状体的缺氧调节
  • 批准号:
    10676923
  • 财政年份:
    2019
  • 资助金额:
    $ 34.68万
  • 项目类别:
Hypoxia Regulation of the Lens
晶状体的缺氧调节
  • 批准号:
    10456991
  • 财政年份:
    2019
  • 资助金额:
    $ 34.68万
  • 项目类别:
Hypoxia Regulation of the Lens
晶状体的缺氧调节
  • 批准号:
    10246917
  • 财政年份:
    2019
  • 资助金额:
    $ 34.68万
  • 项目类别:
Repurposing classical death pathways for signaling roles in lens differentiation
重新利用经典死亡途径在晶状体分化中发挥信号作用
  • 批准号:
    9054227
  • 财政年份:
    2015
  • 资助金额:
    $ 34.68万
  • 项目类别:
Regulatory role of PI3K signaling pathways in lens differentiation and function
PI3K信号通路在晶状体分化和功能中的调节作用
  • 批准号:
    10361557
  • 财政年份:
    2015
  • 资助金额:
    $ 34.68万
  • 项目类别:
Repurposing classical death pathways for signaling roles in lens differentiation
重新利用经典死亡途径在晶状体分化中发挥信号作用
  • 批准号:
    9187024
  • 财政年份:
    2015
  • 资助金额:
    $ 34.68万
  • 项目类别:
Regulatory role of PI3K signaling pathways in lens differentiation and function
PI3K信号通路在晶状体分化和功能中的调节作用
  • 批准号:
    9917206
  • 财政年份:
    2015
  • 资助金额:
    $ 34.68万
  • 项目类别:
Regulatory role of PI3K signaling pathways in lens differentiation and function
PI3K信号通路在晶状体分化和功能中的调节作用
  • 批准号:
    10580706
  • 财政年份:
    2015
  • 资助金额:
    $ 34.68万
  • 项目类别:
Molecular Analysis of Microdissected Cataractous Human Lenses
显微解剖白内障人类晶状体的分子分析
  • 批准号:
    7159319
  • 财政年份:
    1999
  • 资助金额:
    $ 34.68万
  • 项目类别:
MOLECULAR ANALY MICRODISSECTED CATARACTOUS HUMAN LENSES
分子分析显微解剖白内障人类晶状体
  • 批准号:
    6384885
  • 财政年份:
    1999
  • 资助金额:
    $ 34.68万
  • 项目类别:

相似海外基金

Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
  • 批准号:
    10667060
  • 财政年份:
    2023
  • 资助金额:
    $ 34.68万
  • 项目类别:
RAMAN SPECTROSCOPIC INVESTIGATION OF LENS AGING & CATARACT FORMATION
镜片老化的拉曼光谱研究
  • 批准号:
    6615258
  • 财政年份:
    2002
  • 资助金额:
    $ 34.68万
  • 项目类别:
Using zebrafish as a model system for investigating lens development, aging and cataract.
使用斑马鱼作为模型系统来研究晶状体发育、衰老和白内障。
  • 批准号:
    10046498
  • 财政年份:
    2001
  • 资助金额:
    $ 34.68万
  • 项目类别:
RAMAN SPECTROSCOPIC INVESTIGATION OF LENS AGING & CATARACT FORMATION
镜片老化的拉曼光谱研究
  • 批准号:
    6314167
  • 财政年份:
    2000
  • 资助金额:
    $ 34.68万
  • 项目类别:
RAMAN SPECTROSCOPIC INVESTIGATION OF LENS AGING & CATARACT FORMATION
镜片老化的拉曼光谱研究
  • 批准号:
    6121253
  • 财政年份:
    1999
  • 资助金额:
    $ 34.68万
  • 项目类别:
RAMAN SPECTROSCOPIC INVESTIGATION OF LENS AGING & CATARACT FORMATION
镜片老化的拉曼光谱研究
  • 批准号:
    6281796
  • 财政年份:
    1998
  • 资助金额:
    $ 34.68万
  • 项目类别:
RAMAN SPECTROSCOPIC INVESTIGATION OF LENS AGING & CATARACT FORMATION
镜片老化的拉曼光谱研究
  • 批准号:
    6252366
  • 财政年份:
    1997
  • 资助金额:
    $ 34.68万
  • 项目类别:
Cataract And Lens Aging Study With The Dynamic Light Sca
使用动态光扫描仪进行白内障和晶状体老化研究
  • 批准号:
    6826923
  • 财政年份:
  • 资助金额:
    $ 34.68万
  • 项目类别:
Cataract And Lens Aging Study With The Dynamic Light Sca
使用动态光扫描仪进行白内障和晶状体老化研究
  • 批准号:
    6672792
  • 财政年份:
  • 资助金额:
    $ 34.68万
  • 项目类别:
FAMILY DATA OPHTHALMOLOGIC GENETIC ANALYSIS: AGING CATARACT GLAUCOMA MACULOPATHY
家庭数据眼科遗传分析:老年性白内障、青光眼、黄斑病变
  • 批准号:
    5224657
  • 财政年份:
  • 资助金额:
    $ 34.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了